Infertility Clinical Trial
Official title:
Oocyte Cryopreservation: A Pilot Study Comparing Fertilization and Embryo Development Between Fresh and Vitrified Sibling Oocytes
Vitrification is a method to cryopreserve biological specimens that are sensitive to
chilling injury such as oocytes and embryos, and it has been employed with increased
survival rate and live births (Hong et al., 1999; Kuleshova et al., 1999; Yoon et al., 2000;
Chung et al 2000; Wu et al., 2001: Kuwayama et al 2006). In their study the researchers
propose to directly compare oocyte survival, fertilizaton and embryo development between
sibling oocytes.
The Cryotop method of vitrification, which the researchers aim to investigate in their
study, has been reported as the most efficient method for human oocytes cryopreservation
(Kuwayama et al, 2005, Antinori et al, 2006, Lucena et al, 2006, Cobo et al, 2008). Follow
up of over 200 infants conceived from vitrified oocytes (Chian et al, 2008) indicate that
the mean birth weight and the incidence of congenital anomalies are comparable to that of
spontaneous conceptions in fertile women or infertile women undergoing IVF treatment.
The necessity to cryopreserve human oocytes successfully, with the goal of achieving term
pregnancies at rates equivalent to those obtained with fresh oocytes is urgent.
Cryopreservation of oocytes is desirable because: 1) it would allow infertility patients to
store excess oocytes instead of embryos, eliminating some of the ethical and religious
concerns that accompany embryo storage; 2) permit storage of donor oocytes in egg banks,
analogous to existing sperm banks. This option would allow the cryopreserved oocytes to be
quarantined until screening for infectious diseases is completed, and would also avoid
donor-recipient synchronization difficulties; and 3) can help cancer patients preserve their
fertility before they face sterilization due to chemotherapy or radiation. Oocyte
cryopreservation is therefore gaining in popularity as an option for infertility treatment
as well as fertility preservation.
This is a pilot study to evaluate the outcomes of oocyte vitrification using the Cryotop
method in women undergoing IVF, by simultaneously evaluating embryos derived from vitrified
and fresh oocytes coming from the same stimulated cycle.
The primary outcome measures that will be tracked and tabulated are oocyte survival,
fertilization and cleavage rate, and subsequent embryo development, compared between
vitrified and fresh oocytes. Secondary outcomes are implantation, clinical pregnancy,
miscarriage and live birth rates using embryos derived from the vitrified oocytes for
transfer.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A |